Subscription Center
Jun 10, 2009
Until now, cancer treatments prescribed by veterinarians were human-friendly formulas that hadn't yet been tested for canine companions. But the U.S. Food and Drug Administration has recently approved the first cancer drug for dogs.
The new dog-only drug, Palladia (toceranib phosphate), will be made by international pharmaceutical giant Pfizer and is slated to hit shelves some time next year. It's been approved to treat canine cutaneous cancer—which accounts for about 20 percent of doggie skin tumors and, if left alone, can spread to other parts of the body.
The drug stops new blood vessels from being created—a process called angiogenesis—thereby halting the nutrient and oxygen supply that the tumors need to grow. Angiogenesis inhibitors, such as Avastin (bevacizumab)—approved in 2004 for people—were big news in the late 1990s, when they showed great promise for targeting tumors in early clinical human trials.
May 27, 2009 | 6
.jpg)
You remember the time as a kid when you set an ant on fire. You positioned your dad’s magnifying glass a few inches above the ground, adjusting the angle ever so slightly until the spotlight of refracted rays rested precisely on your target.* Then you waited.
It was innocent fun—except for some of us more sensitive folk—a sort of right-of-passage, backyard science experiment. But would you recall that lesson twenty years later while placing Fido’s clear glass water bowl on your deck?
Investigators of a house fire in Bellevue, Wash., last week are suggesting an elevated 11-inch wide glass bowl of water magnified the sun’s rays onto a wood deck, sparking a blaze that caused more than $200,000 worth of damage. Fortunately, nobody—including the two dogs—was injured.
See what we're tweeting about
sciam Hard To Beat Feet For Fostering Fungus http://t.co/3leNLaLecO sciam How to Use the Bathroom on a 20-Hour Plus Solar Airplane Flight [Video] http://t.co/hnZcerJ9k9 sciam The Moon has it all: Explosions, Water, and Clues to the Grand Tack http://t.co/UL1WcpjmLn
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
